REVB - Financial Reports List - Revelation Biosciences, Inc. - IntrinsicAlpha

Revelation Biosciences, Inc. REVB

Healthcare - Biotechnology - NASDAQ - US

$ 2.61

2.19 %

$ 2.52 M

Market Cap

-0.03

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	23.51%	-10.14%
Quarterly Report	Q4	8-K	2024-12-31	-28.24%	21.66%	24.59%
Annual Report	FY	10-K	2024-12-31	0.00%	-12505543.06%	7.87%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	14.72%	35.32%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-479.34%	-30.49%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-19.24%	-17.43%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-83.37%	-90.91%
Annual Report	FY	10-K	2023-12-31	0.00%	98.89%	20.32%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-130.15%	-131.59%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	19.94%	-3.90%

1